| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 216.53B | 220.11B | 231.04B | 227.27B | 193.43B | 161.44B |
| Gross Profit | 28.91B | 28.79B | 31.77B | 30.90B | 25.93B | 21.11B |
| EBITDA | 10.24B | 10.98B | 12.40B | 11.55B | 8.03B | 5.26B |
| Net Income | 6.42B | 7.05B | 8.47B | 7.84B | 5.14B | 3.46B |
Balance Sheet | ||||||
| Total Assets | 159.34B | 165.42B | 178.28B | 153.63B | 135.17B | 120.27B |
| Cash, Cash Equivalents and Short-Term Investments | 20.33B | 24.27B | 14.95B | 11.60B | 11.32B | 19.09B |
| Total Debt | 10.71B | 10.61B | 14.71B | 6.88B | 5.06B | 2.15B |
| Total Liabilities | 64.39B | 70.42B | 85.71B | 68.99B | 57.93B | 45.06B |
| Stockholders Equity | 94.94B | 94.99B | 92.57B | 84.64B | 77.24B | 75.21B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 16.10B | 718.00M | -681.00M | -8.38B | 4.35B |
| Operating Cash Flow | 0.00 | 16.46B | 2.13B | -285.00M | -7.59B | 4.95B |
| Investing Cash Flow | 0.00 | -830.00M | -1.29B | 210.00M | -968.00M | -1.30B |
| Financing Cash Flow | 0.00 | -9.35B | 2.27B | 88.00M | 702.00M | -1.83B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥792.45B | 26.71 | 13.15% | 0.23% | 2.66% | 7.90% | |
78 Outperform | ¥697.86B | 15.50 | 8.07% | 2.85% | 11.18% | -0.75% | |
74 Outperform | ¥70.73B | 8.83 | ― | 3.17% | -2.96% | 6.43% | |
74 Outperform | ¥89.16B | 12.79 | ― | 2.20% | 4.75% | 164.54% | |
70 Outperform | ¥80.96B | 10.57 | ― | 3.05% | 10.79% | 12.28% | |
64 Neutral | ¥167.94B | 29.59 | 5.91% | 2.39% | -3.24% | -25.21% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |